<kbd dir="jQeml"></kbd>
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. VSports app下载.

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

Review
. 2015 Jun-Sep;28(2-3):155-61.
doi: 10.1016/j.beha.2015.10.013. Epub 2015 Oct 22.

Role of intestinal microbiota in transplantation outcomes

Ying Taur  1 , Robert R Jenq  2 , Carles Ubeda  3 , Marcel van den Brink  4 , Eric G Pamer  5
Affiliations
Review

Role of intestinal microbiota in transplantation outcomes (V体育官网)

Ying Taur et al. Best Pract Res Clin Haematol. 2015 Jun-Sep.

Abstract

While allogeneic hematopoietic stem cell transplantations have a curative potential, infections and graft-versus-host disease remain significant problems. The intestinal microbiota can influence responses to cancer chemotherapy and the role of the microbiota in affecting allogeneic hematopoietic stem cell transplantation outcomes is increasingly appreciated. The following paper discusses the most recent developments in this area. VSports手机版.

Trial registration: ClinicalTrials. gov NCT02269150. V体育安卓版.

Keywords: Allo-HSCT; Bacteremia; Diversity; Intestinal microbiota; Metronidazole; Microbial dominance; Mortality; Survival. V体育ios版.

PubMed Disclaimer

"V体育官网" Conflict of interest statement

Conflict of interest

Eric G V体育平台登录. Pamer: No relevant financial relationships with any commercial interest.

Figures

Figure 1
Figure 1
VRE dominates the intestinal microbiota in humans prior to invading the bloodstream [11]. Stool samples from 5 patients (A–E) were studied prior to and during the transplant period. Each bar on the graph depicts the microbiota of 1 stool sample. Days the samples were collected relative to the day of transplant are indicated along the x-axis. The red horizontal bars indicate the timing of vancomycin-resistant Enterococcus bloodstream infections in patients A and B. Republished with permission of Journal of Clinical Investigation, from Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans, Ubeda C et al, volume 120, number 12, copyright 2010; permission conveyed through Copyright Clearance Center, Inc.
Figure 2
Figure 2
Risk of intestinal domination of the microbiota increases over time following allo-HSCT [12]. This Kaplan-Meier plot shows intestinal domination by Enteroccocus (top), Streptococcus (middle), and Proteobacteria (bottom) at various times throughout the transplant observation period. Republished by permission of Oxford University Press and the Infectious Diseases Society of America. Taur Y, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55:905–914.
Figure 3
Figure 3
Intestinal microbiota diversity decreases following allo-HSCT [12]. A microbiota diversity trend, solid black line, was calculated for each fecal specimen of each patient during the transplant period using the Shannon diversity index. The gray area indicates the 95% confidence interval. Intestinal microbiota diversity decreased after allo-HSCT (Day 0). Republished by permission of Oxford University Press and the Infectious Diseases Society of America. Taur Y, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55:905–914.
Figure 4
Figure 4
Loss of microbiota diversity following allo-HSCT is variable [12]. The microbiota diversity of 3 patients following allo-HSCT is depicted here. The vertical bars represent the microbial composition of a single fecal sample, and the horizontal bars indicate antibiotics administered concurrently. As can be seen, the diversity is variable from patient to patient. Republished by permission of Oxford University Press and the Infectious Diseases Society of America. Taur Y, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55:905–914.
Figure 4
Figure 4
Loss of microbiota diversity following allo-HSCT is variable [12]. The microbiota diversity of 3 patients following allo-HSCT is depicted here. The vertical bars represent the microbial composition of a single fecal sample, and the horizontal bars indicate antibiotics administered concurrently. As can be seen, the diversity is variable from patient to patient. Republished by permission of Oxford University Press and the Infectious Diseases Society of America. Taur Y, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55:905–914.
Figure 5
Figure 5
After transplant engraftment: Intestinal microbial diversity correlates with survival [13]. This research was originally published in Blood. Taur Y, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 2014;124:1174–1182. © the American Society of Hematology.
Figure 6
Figure 6
Transplant-related mortality is markedly reduced in patients with a diverse microbiota following engraftment [13]. This research was originally published in Blood. Taur Y, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 2014;124:1174–1182. © the American Society of Hematology.
See this image and copyright information in PMC

References

    1. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635–1638. - PMC - PubMed
    1. Vollaard EJ, Clasener HA. Colonization resistance. Antimicrob Agents Chemother. 1994;38:409–414. - PMC - PubMed
    1. Hentges DJ, Freter R. In vivo and in vitro antagonism of intestinal bacteria against Shigella flexneri. I. Correlation between various tests. J Infect Dis. 1962;110:30–37. - "V体育2025版" PubMed
    1. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–214. - PMC - PubMed
    1. Smith MI, Yatsunenko T, Manary MJ, Trehan I, Mkakosya R, Cheng J, et al. Gut microbiomes of Malawian twin pairs discordant for kwashiorkor. Science. 2013;339:548–554. - PMC - PubMed

MeSH terms

"V体育安卓版" Associated data

"VSports app下载" LinkOut - more resources